NF-κB activation is required for cell cycling in fibroblast [56], regenerating liver cells [57], breast cancer cells [58], and HeLa cells whereas NF-κB inhibition impairs cell cycle progression and retardation of G1/S transition [59]. The gene discussed is NFKB1; the disease is breast carcinoma.